Bank of Montreal’s Moderna MRNA Stock Holding History

Bank of Montreal’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,300	Closed	-$2.12M	–	4176
2023 Q4	$2.12M	Hold	21,300	–	–	﹤0.01%	1659
2023 Q3	$2.44M	Hold	21,300	–	–	﹤0.01%	1605
2023 Q2	$2.86M	Buy	+21,300	New	+$2.84M	﹤0.01%	1621
2023 Q1	–	Sell	-30,900	Closed	-$6.49M	–	4044
2022 Q4	$6.49M	Sell	30,900 -7,500	-20%	-$1.23M	﹤0.01%	1173
2022 Q3	$5.46M	Buy	38,400 +20,000	+109%	+$3.03M	﹤0.01%	1306
2022 Q2	$2.68M	Sell	18,400 -23,700	-56%	-$3.39M	﹤0.01%	1752
2022 Q1	$7.62M	Buy	42,100 +23,700	+129%	+$3.99M	﹤0.01%	1271
2021 Q4	$4.63M	Buy	+18,400	New	+$5.38M	﹤0.01%	1261

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Bank of Montreal's MRNA Position: Q2 2026 in Review

Bank of Montreal increased its Moderna (MRNA) stake by 31% in Q2 2026, buying an estimated $4.76M and bringing the position to 389,789 shares worth $27.3M. The position accounts for 0.01% of the portfolio, ranked #793.

Bank of Montreal first reported a position in MRNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $234M in Q4 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Bank of Montreal held 389,789 shares of Moderna worth $27.3M as of Q2 2026.
Bank of Montreal bought 91,986 Moderna shares in Q2 2026, an estimated $4.76M.
Moderna made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #793 holding.
Bank of Montreal first reported a position in Moderna in Q1 2019 and has held it in 30 quarters since.
Bank of Montreal's Moderna position peaked at $234M in Q4 2021.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.